Status:
TERMINATED
Study of Glaucoma Treatment With Food Additives
Lead Sponsor:
Future Products Management
Conditions:
Glaucomatous Neuropathy
Eligibility:
All Genders
40-75 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine if certain food additives are effective in the treatment of glaucoma, improving and reversing the progress of the disease.
Detailed Description
Glaucomatous neuropathy is a condition that worsens with time causing atrophy of the optic nerve and narrowing of the visual field which may culminate in blindness. The treatment tested in the trial e...
Eligibility Criteria
Inclusion
- Stable open angle glaucoma - with equilibrated eye internal pressure
- Above the age of 50 years and have severe damage that does not progress to the vision field in the upper and lower half. Scoring of the vision field will be made according to the Agis study instructions.
Exclusion
- Eye diseases excluding past cataract operation
- Allergy to one of the components in the preparation
- Deterioration in the vision field in the last year
- Kidney diseases, gastrointestinal (G.I.) tract, liver diseases, coagulation problems and thyroid diseases
- Persons who take steroids
- Diabetics or unbalanced hyperglycemia
- Autoimmune diseases
- Hypertension (not responding to treatment)
- Psychiatric treatment with drugs, psychiatric pathologies
- Pregnancy
- Ability to take more than 3 pills per day regularly
- Smoking
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00196677
Start Date
September 1 2005
End Date
October 1 2008
Last Update
March 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Tel Litwinsky, Israel, 52621